Lupin receives final approval for Fluocinonide Topical Solution

Explore Business Standard

From USFDA
Lupin has received final approval for its Fluocinonide Topical Solution USP, 0.05% from the United States Food & Drug Administration to market a generic version of County Line Pharmaceuticals, LLC's Fluocinonide Topical Solution USP, 0.05%.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
First Published: Jul 24 2017 | 2:57 PM IST